Advertisement

Advertisement

WALD Stock Latest News

Waldencast Unveils Post-Obagi Strategy as Milk Makeup-Only Company After H1 2026 Slump

Company AnnouncementsWaldencast Unveils Post-Obagi Strategy as Milk Makeup-Only Company After H1 2026 Slump

Waldencast Moves to Delist from Nasdaq and Halt SEC Reporting

PremiumCompany Announcements

Waldencast Moves to Delist from Nasdaq and Halt SEC Reporting

10d ago

Waldencast to voluntarily delist from Nasdaq and deregister its securities

PremiumThe Fly

Waldencast to voluntarily delist from Nasdaq and deregister its securities

10d ago

Waldencast to Delist from Nasdaq and Rebrand as Milk Makeup plc

PremiumCompany Announcements

Waldencast to Delist from Nasdaq and Rebrand as Milk Makeup plc

21d ago

Waldencast to voluntarily delist from Nasdaq

PremiumThe Fly

Waldencast to voluntarily delist from Nasdaq

21d ago

Closing Bell Movers: Dell rallies after Q2 earnings beat

PremiumThe FlyClosing Bell Movers: Dell rallies after Q2 earnings beat

1M ago

Waldencast director buys $505.6K in common stock

The Fly

Waldencast director buys $505.6K in common stock

1M ago

Waldencast Shareholders Back Board, Auditor and Five-Year Share Buyback Authority

Company Announcements

Waldencast Shareholders Back Board, Auditor and Five-Year Share Buyback Authority

2M ago

Waldencast Finalizes Obagi Medical Sale, Refocuses on Milk Makeup and Repays Debt

PremiumCompany Announcements

Waldencast Finalizes Obagi Medical Sale, Refocuses on Milk Makeup and Repays Debt

2M ago

Waldencast Closes $460 Million Sale of Obagi Medical, Refocuses on Milk Makeup

PremiumCompany Announcements

Waldencast Closes $460 Million Sale of Obagi Medical, Refocuses on Milk Makeup

2M ago

Waldencast Sets August AGM as Board Reshapes Around Milk Makeup Focus

PremiumCompany Announcements

Waldencast Sets August AGM as Board Reshapes Around Milk Makeup Focus

3M ago

Waldencast Delays Warrant Issuance to November as Obagi Wins FDA Nod for saypha ChIQ

PremiumCompany Announcements

Waldencast Delays Warrant Issuance to November as Obagi Wins FDA Nod for saypha ChIQ

4M ago

Waldencast announces regulatory approval of Obagi dermal filler

PremiumThe FlyWaldencast announces regulatory approval of Obagi dermal filler

4M ago

Waldencast price target raised to $3 from $2 at Canaccord

The Fly

Waldencast price target raised to $3 from $2 at Canaccord

4M ago

Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup

Company Announcements

Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup

4M ago

Waldencast to sell Obagi Medical to Bridgepoint for up to $460M

PremiumThe Fly

Waldencast to sell Obagi Medical to Bridgepoint for up to $460M

4M ago

WALD Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

WALD Earnings Report this Week: Is It a Buy, Ahead of Earnings?

4M ago

PremiumRatings

Waldencast: Regulatory Overhang Cleared, Brand Growth Prospects Support Buy Rating and Unchanged $2 Price Target

5M ago

Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues

PremiumCompany Announcements

Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues

5M ago

Obagi Medical, ProMD collaborate for ALOHA program

PremiumThe FlyObagi Medical, ProMD collaborate for ALOHA program

7M ago

Obagi Medical, ProMD collaborate for ALOHA program

The Fly

Obagi Medical, ProMD collaborate for ALOHA program

7M ago

Waldencast price target lowered to $2.50 from $3.50 at Alliance Global

The Fly

Waldencast price target lowered to $2.50 from $3.50 at Alliance Global

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >